Literature DB >> 19377997

Nucleic acid pool preparation and characterization.

Shawn K Piasecki1, Bradley Hall, Andrew D Ellington.   

Abstract

Random sequence nucleic acid pools can be used in a variety of applications, including the selection of functional nucleic acids such as protein binding sites, aptamers, and ribozymes. while the design, synthesis, and purification of pools is relatively straightforward, keeping track of the size and complexity of a nucleic acid pool can sometimes task even an experienced researcher. The following protocol takes the reader through the steps necessary for the preparation of a pool of known complexity.

Mesh:

Substances:

Year:  2009        PMID: 19377997     DOI: 10.1007/978-1-59745-557-2_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Selection of RNA aptamers imported into yeast and human mitochondria.

Authors:  Olga Kolesnikova; Helena Kazakova; Caroline Comte; Sergey Steinberg; Piotr Kamenski; Robert P Martin; Ivan Tarassov; Nina Entelis
Journal:  RNA       Date:  2010-03-26       Impact factor: 4.942

2.  Characterization of homing endonuclease binding and cleavage specificities using yeast surface display SELEX (YSD-SELEX).

Authors:  Kyle Jacoby; Abigail R Lambert; Andrew M Scharenberg
Journal:  Nucleic Acids Res       Date:  2017-02-17       Impact factor: 16.971

3.  Optimization of RNA Aptamer SELEX Methods: Improved Aptamer Transcript 3'-End Homogeneity, PAGE Purification Yield, and Target-Bound Aptamer RNA Recovery.

Authors:  Chandan Narayan; Suresh Veeramani; William H Thiel
Journal:  Nucleic Acid Ther       Date:  2021-11-10       Impact factor: 5.486

4.  Development of a novel, high-affinity ssDNA trypsin inhibitor.

Authors:  Stanislaw Malicki; Miroslaw Ksiazek; Pawel Majewski; Aleksandra Pecak; Piotr Mydel; Przemyslaw Grudnik; Grzegorz Dubin
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 5.  Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy.

Authors:  Zhaoying Fu; Jim Xiang
Journal:  Int J Mol Sci       Date:  2020-04-17       Impact factor: 5.923

6.  Development of RNA aptamers as molecular probes for HER2(+) breast cancer study using cell-SELEX.

Authors:  Seyedeh Alia Moosavian; Mahmoud Reza Jaafari; Seyed Mohammad Taghdisi; Fatemeh Mosaffa; Ali Badiee; Khalil Abnous
Journal:  Iran J Basic Med Sci       Date:  2015-06       Impact factor: 2.699

7.  An RNA aptamer possessing a novel monovalent cation-mediated fold inhibits lysozyme catalysis by inhibiting the binding of long natural substrates.

Authors:  Camille S Padlan; Vladimir N Malashkevich; Steve C Almo; Matthew Levy; Michael Brenowitz; Mark E Girvin
Journal:  RNA       Date:  2014-02-25       Impact factor: 4.942

8.  High-affinity RNA Aptamers Against the HIV-1 Protease Inhibit Both In Vitro Protease Activity and Late Events of Viral Replication.

Authors:  Sonald Duclair; Archana Gautam; Andrew Ellington; Vinayaka R Prasad
Journal:  Mol Ther Nucleic Acids       Date:  2015-02-17       Impact factor: 10.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.